Efficacy and safety of fexofenadine HCl in Japanese patients with chronic idiopathic urticaria

International Archives of Allergy and Immunology

Volumn 124, Issue 1-3, 2001, Pages 343-345

  Kawashima, Makoto ^a   Harada, Shotaro ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Kanto Teishin Hospital   (Japan)

Author keywords

Antihistamine; Chronic idiopathic urticaria; Fexofenadine HCl; Japanese patient; Treatment

Indexed keywords

FEXOFENADINE;

CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; PRURITUS; SCORING SYSTEM; SIDE EFFECT; URTICARIA;

EID: 0035053326     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053752     Document Type: Conference Paper

References (2)

1. Multicentre, double-blind, randomized, placebo-controlled study comparing the efficacy and safety of four dosage strengths of fexofenadine HCl (20 mg, 60 mg, 120 mg, 240 mg bid) in the treatment of chronic idiopathic urticaria
2. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria